Nested case control of lipidomics and pancreatic cancer in the plco and atbc cohorts. September 15, 2017 to september 14, 2018. Can # 7-8020425
Ended Awarded Last action
- Contract number
- HHSN26100004
- Awardee
-
Metabolon, Inc. UEI SBY5A7EK9PU3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $491,248
Award facts
- Opportunity
-
- N02CP7100272 Solicitation number
- Metabolomic Profiling for Molecular Epidemiology Studies Award Notice · Posted Oct 31, 2016
- Contract value 100% obligated
- $491,247.97 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Durham, NC 27713, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$9,322 | |
| Supplemental Agreement for work within scope | $24,380 | |
| Original award | $476,190 |
About this award
The Department of Health and Human Services, National Institutes of Health, National Cancer Institute awarded a Firm Fixed Price Delivery Order contract to Metabolon, Inc., a self-certified small disadvantaged business and for-profit organization, to provide metabolomics analysis services for a nested case-control study of lipidomics and pancreatic cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial and Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study cohorts. The contract has a potential value of $491,247.97 and a period of performance from September 15, 2017 to September 14, 2018, with a current completion date of January 17, 2023. This contract is part of the National Cancer Institute's Metabolomic Profiling for Molecular Epidemiology Studies program and does not have a set-aside designation.
Quick answers
Who was awarded contract HHSN26100004?
HHSN26100004 was awarded to Metabolon, Inc. by National Cancer Institute (National Institutes of Health) on September 15, 2017.
How much is contract HHSN26100004 worth?
The government has obligated $491,248 on HHSN26100004.
Is contract HHSN26100004 an order under another contract?
Yes. HHSN26100004 is a delivery order under HHSN261201700009I, an indefinite delivery contract.
Was contract HHSN26100004 competed?
The extent of competition for HHSN26100004 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award